bpc-157 human clinical trials results 2025 2026 Peptide Therapy | Regenerative Medicine Christopher Mendias, PhD, gets four

The study adds legitimacy to user reports of accelerated recovery timelines

GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimers disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway

This finding has clinical relevance for: Diabetic ulcers Pressure sores Surgical wound dehiscence Radiation-induced skin damage Chemical and thermal burns In practice, BPC-157 can be administered topically (in compounded creams), locally (via injection into wound margins), or systemically (subcutaneous injection) depending on the wound type and location

BPC 157 stands for Body Protecting Compound 157

The cycling approach most protocols recommend partly addresses these uncertainties

Without human trials, clinicians cannot reliably determine appropriate dosing, long-term risks or whether benefits outweigh risks